NHSBT selects Amperia RED for rapid at-line AAV vector quantification
April 24, 2025
NHS Blood and Transplant Clinical Biotechnology Centre implements the Amperia system to streamline viral vector process development for novel gene therapies The NHSBT Clinical Biotechnology Centre (CBC), Bristol, one of three government selected Innovation Hubs tasked to accelerate the development of novel gene therapies in the UK, has selected the Amperia Redox Electrochemical Detection (RED) system to [...]
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing
April 24, 2025
Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of [...]
April 24, 2025
Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development Cambridge, UK: CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the life sciences industry. Under [...]
April 24, 2025
ADC assay now available through ABS; customer study proves IO60 is a spatial workhorse MARLBOROUGH, Mass. -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today announced the availability of a new assay designed to advance antibody-drug conjugate (ADC) development in breast cancer. The new assay will be featured alongside customer-generated real-world data from [...]
April 24, 2025
>8,500 samples and 100 million cells of high resolution and fully annotated spatial proteomics data available MARLBOROUGH, Mass. -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Medicine, a real-world data company providing AI-ready patient, cellular and molecular data, today announced a groundbreaking collaboration to deliver the largest commercially available single-cell spatial [...]
April 24, 2025
A Compact Benchtop Optofluidic System with Lower Cost of Ownership for Broader Research Accessibility EMERYVILLE, Calif. -- Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop system offers an accessible entry point into live single-cell functional analysis. Beacon [...]
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
April 24, 2025
New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial biology: a powerful new assay for in situ detection of protein proximity. Built upon Advanced [...]
Stellaromics Announces First Deployment of Pyxa Platform in Europe
April 24, 2025
Early Access Partnership with Dr. Nigel Jamieson to Explore 3D Spatial Biology in Oncology Research BOSTON -- Stellaromics, a pioneer in 3D spatial biology, today announced that Dr. Nigel Jamieson and his team at the University of Glasgow are the first European users of the company's Pyxa platform. As an inaugural early access partner, Dr. Jamieson, a physician-scientist and Professor at the University of [...]
1Cell.Ai and BioSkryb Announce Strategic Partnership to Advance Single Cell Multi-omics Innovation
April 24, 2025
FOSTER CITY, Calif. and DURHAM, N.C. -- 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single cell multi-omic solutions. This collaboration will empower researchers and clinicians to detect and characterize rare mutations in single cells with unprecedented accuracy, facilitating breakthroughs in cancer [...]
April 24, 2025
Company to present four abstracts at the American Association for Cancer Research 2025 annual meeting highlighting research from AVITI24, the Trinity™ workflow solution, and new direct in sample sequencing applications SAN DIEGO -- Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the accelerated rollout and availability of direct in [...]

